Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease.

The American journal of clinical nutrition - 1 May 2013

Suzuki Masahiko, Yoshioka Masayuki, Hashimoto Masaya, Murakami Maiko, Noya Miki, Takahashi Daisuke, Urashima Mitsuyoshi

Abstract excerpt

BACKGROUND: In our previous study, higher serum 25-hydroxyvitamin D [25(OH)D] concentrations and the vitamin D receptor (VDR) FokI CC genotype were associated with milder Parkinson disease (PD). OBJECTIVE: We evaluated whether vitamin D3 supplementation inhibits the progression of PD on the basis of patient VDR subgroups. DESIGN: Patients with PD (n = 114) were randomly assigned to receive vitamin D3 supplements...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to Calcium, Dietary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholecalciferol

Share to Dietary Supplements

Share to Double-Blind Method

Share to Endpoint Determination

Share to Parathyroid Hormone

Share to Receptors, Calcitriol

Source

Identifiers

PMID: 23485413
DOI: 10.3945/ajcn.112.051664

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease.PMID 23485413Read ↗

The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease.Semantic proximity Read ↗

Vitamin D deficiency and genetic polymorphisms of vitamin D-associated genes in Parkinson's disease.Semantic proximity Read ↗

Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis.Semantic proximity Read ↗

25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.Semantic proximity Read ↗

Vitamin D deficiency and genetic polymorphisms of Vitamin D-associated genes in Parkinson's DiseaseSemantic proximity Read ↗

GC and VDR SNPs and Vitamin D Levels in Parkinson's Disease: The Relevance to Clinical Features.Semantic proximity Read ↗

Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.Semantic proximity Read ↗

The VDR FokI (rs2228570) polymorphism is involved in Parkinson's disease.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms and the risk of Parkinson's disease.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and susceptibility to Parkinson's disease and Alzheimer's disease: a meta-analysis.Semantic proximity Read ↗

Association of 25-hydroxyvitamin D with Parkinson's disease based on the results from the NHANES 2007 to 2018 and Mendelian randomization analysis.Semantic proximity Read ↗

No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.